15,826 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Purchased by Focus Partners Wealth

Focus Partners Wealth purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 15,826 shares of the medical instruments supplier's stock, valued at approximately $300,000.

Several other institutional investors have also recently modified their holdings of the stock. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $26,000. Colonial Trust Co SC purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth $26,000. MassMutual Private Wealth & Trust FSB raised its position in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. raised its position in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its position in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after purchasing an additional 1,568 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. UBS Group decreased their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Piper Sandler decreased their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Eleven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $20.36.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.52% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded down $0.38 during midday trading on Friday, reaching $15.47. The company had a trading volume of 2,475,144 shares, compared to its average volume of 2,968,748. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $3.08 billion, a price-to-earnings ratio of -7.47, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The stock has a fifty day simple moving average of $14.47 and a 200 day simple moving average of $17.08. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $28.25.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The company had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's quarterly revenue was down 7.8% compared to the same quarter last year. During the same period last year, the firm posted $0.42 earnings per share. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.14%. DENTSPLY SIRONA's payout ratio is -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.